End-of-day quote
Korea S.E.
06:00:00 2024-07-10 pm EDT
|
5-day change
|
1st Jan Change
|
4,010
KRW
|
-0.12%
|
|
+2.82%
|
-13.95%
|
Mar. 08 |
QuantaMatrix Inc. announced that it has received KRW 17.5 billion in funding from Korea Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., The Korea Securities Finance Corporation, KB Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., Samsung Securities Co., Ltd.
|
CI
| Mar. 07 |
QuantaMatrix Inc. announced that it expects to receive KRW 17.5 billion in funding from Korea Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., The Korea Securities Finance Corporation, KB Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., Samsung Securities Co., Ltd.
|
CI
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
328,270
|
177,950
|
76,135
|
77,064
|
Enterprise Value (EV)
1 |
276,583
|
127,317
|
45,159
|
68,161
|
P/E ratio
|
-19.7
x
|
-8.97
x
|
-3.96
x
|
-3.57
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
194
x
|
324
x
|
59.2
x
|
24.7
x
|
EV / Revenue
|
164
x
|
232
x
|
35.1
x
|
21.9
x
|
EV / EBITDA
|
-21.2
x
|
-7.81
x
|
-2.56
x
|
-3.4
x
|
EV / FCF
|
-31.2
x
|
-9.7
x
|
-4.27
x
|
-4.72
x
|
FCF Yield
|
-3.2%
|
-10.3%
|
-23.4%
|
-21.2%
|
Price to Book
|
5.72
x
|
3.05
x
|
1.91
x
|
4.25
x
|
Nbr of stocks (in thousands)
|
14,655
|
16,477
|
16,479
|
16,537
|
Reference price
2 |
22,400
|
10,800
|
4,620
|
4,660
|
Announcement Date
|
3/23/21
|
3/23/22
|
3/23/23
|
3/21/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
84.94
|
811.4
|
1,689
|
549.8
|
1,286
|
3,118
|
EBITDA
1 |
-10,202
|
-13,137
|
-13,032
|
-16,296
|
-17,641
|
-20,054
|
EBIT
1 |
-11,090
|
-14,574
|
-14,831
|
-18,415
|
-20,018
|
-22,448
|
Operating Margin
|
-13,056.01%
|
-1,796.2%
|
-877.95%
|
-3,349.63%
|
-1,556.68%
|
-719.96%
|
Earnings before Tax (EBT)
1 |
-15,512
|
-63,845
|
-14,718
|
-18,180
|
-19,307
|
-21,630
|
Net income
1 |
-15,512
|
-63,811
|
-14,659
|
-18,116
|
-19,237
|
-21,556
|
Net margin
|
-18,261.83%
|
-7,864.48%
|
-867.72%
|
-3,295.13%
|
-1,495.97%
|
-691.35%
|
EPS
2 |
-15,682
|
-10,207
|
-1,139
|
-1,204
|
-1,167
|
-1,305
|
Free Cash Flow
1 |
-8,075
|
-12,447
|
-8,862
|
-13,132
|
-10,584
|
-14,437
|
FCF margin
|
-9,506.26%
|
-1,534.1%
|
-524.59%
|
-2,388.67%
|
-823.02%
|
-463.04%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/9/19
|
4/2/20
|
3/23/21
|
3/23/22
|
3/23/23
|
3/21/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
32,956
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
24,192
|
51,687
|
50,632
|
30,976
|
8,903
|
Leverage (Debt/EBITDA)
|
-3.23
x
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-8,075
|
-12,447
|
-8,862
|
-13,132
|
-10,584
|
-14,437
|
ROE (net income / shareholders' equity)
|
61.7%
|
6,011%
|
-33.8%
|
-31.3%
|
-39.2%
|
-74.3%
|
ROA (Net income/ Total Assets)
|
-30.5%
|
-28.1%
|
-19.6%
|
-18.4%
|
-22.9%
|
-41.1%
|
Assets
1 |
50,890
|
227,412
|
74,911
|
98,624
|
84,080
|
52,441
|
Book Value Per Share
2 |
-40,668
|
2,372
|
3,917
|
3,544
|
2,420
|
1,096
|
Cash Flow per Share
2 |
2,083
|
235.0
|
647.0
|
547.0
|
123.0
|
415.0
|
Capex
1 |
1,090
|
1,005
|
1,108
|
2,763
|
485
|
861
|
Capex / Sales
|
1,282.96%
|
123.84%
|
65.6%
|
502.59%
|
37.69%
|
27.61%
|
Announcement Date
|
4/9/19
|
4/2/20
|
3/23/21
|
3/23/22
|
3/23/23
|
3/21/24
|
|
1st Jan change
|
Capi.
|
---|
| -13.95% | 48.02M | | +99.39% | 7.36B | | -21.23% | 6.62B | | +7.89% | 5.73B | | -22.19% | 3.46B | | +6.24% | 2.5B | | +35.32% | 2.28B | | -7.91% | 2.22B | | -69.64% | 1.88B | | -18.50% | 1.57B |
Diagnostic & Testing Substances
|